Ares Capital Corporation's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Interest-Expense" stands at 713.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Ares Capital Corporation's third quarter result of 195.00 Million USD for the item "Interest Expense" represents an increase of 13.37 percent compared to it's second quarter result.
Also, Ares Capital Corporation's third quarter result of 195.00 Million USD for the item "Interest Expense" represents an increase of 7.73 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Ares Capital Corporation's third quarter result of 713.00 Million USD for the item "Interest Expense" represents an increase of 2.00 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.35 percent compared to the value the year prior.
The 1 year change in percent is 13.35.
The 3 year change in percent is 98.06.
The 5 year change in percent is 159.27.
The 10 year change in percent is 212.87.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Interest Expense | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Interest Expense | 186,696,990,720.00 |
![]() | BlackRock Inc - Interest Expense | 166,346,604,544.00 |
![]() | KKR & Co LP - Interest Expense | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Interest Expense | 101,856,345,600.00 |